000 a
999 _c9647
_d9647
003 OSt
005 20191009142207.0
008 191009b xxu||||| |||| 00| 0 eng d
040 _aAIKTC-KRRC
_cAIKTC-KRRC
100 _99805
_aBhatia, Anuradha
245 _aEfficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin
_b: A prospective, randomized comparative study
250 _aVol.51(2), March-April
260 _aMumbai
_bWolter Kluwer
_c2019
300 _a116-119p.
520 _aOBJECTIVES: Dermatophytic infections are the common fungal infections aggravated by hot and humid climate. Terbinafine and itraconazole are commonly used oral antifungal agents for the same. However, resistance to these drugs is being seen increasingly when used in the conventional doses and duration. Therefore, this study was designed to compare the efficacy of terbinafine and itraconazole in increased dosages and duration in the treatment of tinea corporis and tinea cruris. MATERIALS AND METHODS: In this randomized comparative study, patients of tinea cruris and tinea corporis were randomly divided into two groups of 160 each and were given oral terbinafine (Group I) and oral itraconazole (Group II) for 4 weeks. The scores and percentage change in scores of pruritus, scaling, and erythema were evaluated at 2 and 4 weeks. RESULTS: At the end of week 4, mycological cure was seen in 91.8% after 4 weeks in the itraconazole group as compared to 74.3% of patients in the terbinafine group. There was a significant improvement in percentage change in pruritus, scaling, and erythema in both the groups from 0 to 4 weeks. On comparing groups, the percentage change was significantly different in scaling from 0 to 2 weeks (5.4 vs. −4.8) and 2–4 weeks (16.7 vs. 29.6) between Group I and Group II, respectively. Clinical global improvement was better with itraconazole. Mild adverse effects such as gastrointestinal upset, headache, and taste disturbances were observed which were comparable in both the groups. CONCLUSIONS: Itraconazole and terbinafine seem to be equally effective and safe in the treatment of tinea cruris and tinea corporis.
650 0 _94774
_aPHARMACOLOGY
700 _99806
_aKanish, Bimal
773 0 _x0253-7613
_tIndian Journal of Pharmacology
_dAndheri - Mumbai Wolters Kluwer India Private Limited
856 _uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533924/
_yClikc here
942 _2ddc
_cAR